Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Net Income Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Net Income
kr7.5B
CAGR 3-Years
35%
CAGR 5-Years
44%
CAGR 10-Years
50%
Zealand Pharma A/S
CSE:ZEAL
Net Income
-kr712m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
Ascendis Pharma A/S
NASDAQ:ASND
Net Income
-€489.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Net Income
kr707.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
88%
F
Fluoguide AS
STO:FLUO
Net Income
-kr43.9m
CAGR 3-Years
-26%
CAGR 5-Years
-283%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Net Income
-kr55.9m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
-11%

See Also

What is Genmab A/S's Net Income?
Net Income
7.5B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Net Income amounts to 7.5B DKK.

What is Genmab A/S's Net Income growth rate?
Net Income CAGR 10Y
50%

Over the last year, the Net Income growth was 26%. The average annual Net Income growth rates for Genmab A/S have been 35% over the past three years , 44% over the past five years , and 50% over the past ten years .

Back to Top